Healthy Clinical Trial
Official title:
The Genetics of Environmental Asthma: LPS Inhalation and Bronchoscopy in Normal Subjects and Subjects With Mild Atopic Asthma
The purpose of this study is to identify the mediators and genes in airway epithelial and
BAL cells that are differentially regulated following inhalation of endotoxin
lipopolysaccharide (LPS) among study participants with allergic asthma and normal
phenotypes. This approach is designed to identify novel genes associated with both asthma
pathogenesis and asthma susceptibility. LPS, or endotoxin, a cell wall component of
gram-negative bacteria, is ubiquitous in the environment, and is thought to influence both
susceptibility and severity of asthma.
240 subjects (healthy adult men and women (age >18-40) with and without atopy and asthma)
will complete the screening evaluations in order to establish 3 study groups of 60 subjects
each. Each qualified subject will undergo an inhaled LPS endotoxin challenge followed by
bronchoscopy after 24 hours, which will consist of a bronchoalveolar lavage (BAL) and
endobronchial brush biopsies. BAL involves squirting a small amount of sterile salt water
into one of the airways then gently taking it back out through the bronchoscope. The brush
sample involves gently moving a small brush back and forth in an airway to collect cell
samples. Samples of whole blood will also be obtained at various time points. RNA will be
isolated from these cell populations in order to assess differential gene expression
expression using microarrays.
Background:
Endotoxin or lipopolysaccharide (LPS), a cell wall component of gram-negative bacteria, is
ubiquitous in the environment, and is often present in high concentrations in organic dusts,
as well as in air pollution, and household dusts. There is convincing evidence that
endotoxin exacerbates airflow obstruction and airway inflammation in allergic asthmatics.
Additional findings indicate that allergic airways can enhance the response to inhaled
endotoxin, and that endotoxin can enhance the airway response to allergens. However, when
considering the interaction between endotoxin and allergens, the timing of the exposure
appears to be critical. Emerging evidence suggests that early exposure to endotoxin, a
potent inducer of Th1 type cytokines (IFN-g and IL-12), may minimize the risk of allergen
sensitization which could has profound effects on reducing the risk of developing asthma in
children. Independent of its effect in allergic asthma, several studies demonstrate that
inhalation of air contaminated with endotoxin is associated with the classical features of
asthma (reversible airflow obstruction and airway inflammation, and persistent airway
hyperreactivity and airway remodeling). Epidemiological studies have shown that the
concentration of inhaled endotoxin in the bioaerosol is strongly and consistently associated
with reversible airflow obstruction among cotton workers, agricultural workers, and
fiberglass workers. Importantly, the concentration of endotoxin in the bioaerosol is the
most important occupational exposure associated with the development and progression of
airway disease in agricultural workers. Experimentally, inhalation of endotoxin can cause
reversible airflow obstruction and airway inflammation in previously unexposed healthy study
subjects. The ability of the host to respond to endotoxin is highly variable, and is
influenced in part by genetic factors.:
The rationale for this investigation is based on the following points:
- asthma is caused in large part by both genetic susceptibility and environmental
exposure,
- a variety of immune and non-immune mechanisms can function independently or
interactively to cause airway hyper-reactivity, airflow obstruction, airway
inflammation, and airway remodeling,
- environmental challenges can be used to "narrow the asthma phenotype" and allow one to
investigate unique gene-environment interactions that are involved in the development
of biologically specific forms of asthma,
- genes that are over or under stimulated in the airway epithelia of asthmatics following
inhalation challenge are important in the pathogenesis of asthma
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |